Archive: 30/09/2018
New cancer vaccine shows early promise for patients with HER2-positive cancers
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according ...
Sep 30, 2018
Bacterial therapy tolerable, shows early promise in patients with advanced solid tumors
A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid ...
Sep 30, 2018
Patient-partnered genomics study IDs immunotherapy as potential treatment for rare cancer
Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp (HFNS), according to data ...
Sep 30, 2018